Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
PPP3CA
Introduction
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (PP2BA) is a protein that in humans is encoded by the PPP3CA gene.[1][2]
References
References
- ↑ Universal protein resource accession number Q08209 for “Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform” at UniProt.
- ↑ “Entrez Gene: Protein phosphatase 3, catalytic subunit, alpha isozyme”. Retrieved 2011-12-18.
Further reading
Further reading
- Crabtree GR (March 1999). “Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT”. Cell. 96 (5): 611–4. doi:10.1016/S0092-8674(00)80571-1. PMID 10089876.
- Wang HG, Pathan N, Ethell IM, Krajewski S, Yamaguchi Y, Shibasaki F, McKeon F, Bobo T, Franke TF, Reed JC (April 1999). “Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD”. Science. 284 (5412): 339–43. doi:10.1126/science.284.5412.339. PMID 10195903.
- Fuentes JJ, Genescà L, Kingsbury TJ, Cunningham KW, Pérez-Riba M, Estivill X, de la Luna S (July 2000). “DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways”. Human Molecular Genetics. 9 (11): 1681–90. doi:10.1093/hmg/9.11.1681. PMID 10861295.
- Frey N, Richardson JA, Olson EN (December 2000). “Calsarcins, a novel family of sarcomeric calcineurin-binding proteins”. Proceedings of the National Academy of Sciences of the United States of America. 97 (26): 14632–7. doi:10.1073/pnas.260501097. PMC 18970. PMID 11114196.
- Siddiq A, Miyazaki T, Takagishi Y, Kanou Y, Hayasaka S, Inouye M, Seo H, Murata Y (May 2001). “Expression of ZAKI-4 messenger ribonucleic acid in the brain during rat development and the effect of hypothyroidism”. Endocrinology. 142 (5): 1752–9. doi:10.1210/en.142.5.1752. PMID 11316738.
- Graef IA, Chen F, Chen L, Kuo A, Crabtree GR (June 2001). “Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature”. Cell. 105 (7): 863–75. doi:10.1016/S0092-8674(01)00396-8. PMID 11439183.
- Mukerjee N, McGinnis KM, Gnegy ME, Wang KK (August 2001). “Caspase-mediated calcineurin activation contributes to IL-2 release during T cell activation”. Biochemical and Biophysical Research Communications. 285 (5): 1192–9. doi:10.1006/bbrc.2001.5278. PMID 11478781.
- Volkel H, Scholz M, Link J, Selzle M, Werner P, Tunnemann R, Jung G, Ludolph AC, Reuter A (August 2001). “Superoxide dismutase mutations of familial amyotrophic lateral sclerosis and the oxidative inactivation of calcineurin”. FEBS Letters. 503 (2–3): 201–5. doi:10.1016/S0014-5793(01)02730-2. PMID 11513882.
- Esau C, Boes M, Youn HD, Tatterson L, Liu JO, Chen J (November 2001). “Deletion of calcineurin and myocyte enhancer factor 2 (MEF2) binding domain of Cabin1 results in enhanced cytokine gene expression in T cells”. The Journal of Experimental Medicine. 194 (10): 1449–59. doi:10.1084/jem.194.10.1449. PMC 2193671. PMID 11714752.
- Frey N, Olson EN (April 2002). “Calsarcin-3, a novel skeletal muscle-specific member of the calsarcin family, interacts with multiple Z-disc proteins”. The Journal of Biological Chemistry. 277 (16): 13998–4004. doi:10.1074/jbc.M200712200. PMID 11842093.